Skip to main content

Advertisement

Log in

Emerging issues in the neuropsychology of HIV infection

  • Published:
Current HIV/AIDS Reports Aims and scope Submit manuscript

Abstract

Neurocognitive compromise, a common sequela of HIV infection, ranges in severity from minor motor and information-processing speed decrements to severely incapacitating symptoms that affect functional independence. However, with the emergence of highly active antiretroviral therapy (HAART), neurocognitive phenotypes have become highly heterogeneous and increasingly fail to resemble pre-HAART presentations. This article provides an overview of our current knowledge of HIV-associated neuropsychological abnormalities, with an emphasis on the most recent attempts to classify cognitive impairment within Western and developing societies, the emergence of diverse cognitive presentations in the post-HAART era, factors that moderate the development or impact of HIV-related neurocognitive and functional deficits, and the neurophysiologic consequences of infection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Ances BM, Ellis RJ: Dementia and neurocognitive disorders due to HIV-1 infection. Semin Neurol 2007, 27:86–92.

    Article  PubMed  Google Scholar 

  2. Heaton RK, Grant I, Butters N, et al.: The HNRC 500—neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc 1995, 1:231–251.

    PubMed  CAS  Google Scholar 

  3. Heaton RK, Marcotte TD, Mindt MR, et al.: The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc 2004, 10:317–331.

    Article  PubMed  Google Scholar 

  4. Hinkin CH, Castellon SA, Durvasula RS, et al.: Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity. Neurology 2002, 59:1944–1950.

    PubMed  CAS  Google Scholar 

  5. Marcotte TD, Heaton RK, Wolfson T, et al.: The impact of HIV-related neuropsychological dysfunction on driving behavior. The HNRC Group. J Int Neuropsychol Soc 1999, 5:579–592.

    Article  PubMed  CAS  Google Scholar 

  6. Moore DJ, Masliah E, Rippeth JD, et al.; HNRC Group: Cortical and subcortical neurodegeneration is associated with HIV neurocognitive impairment. AIDS 2006, 20:879–887.

    Article  PubMed  Google Scholar 

  7. Brew BJ: Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex. AIDS 2004, 18(Suppl 1):S75–S78.

    PubMed  CAS  Google Scholar 

  8. Paul RH, Yiannoutsos CT, Miller EN, et al.: Proton MRS and neuropsychological correlates in AIDS dementia complex: evidence of subcortical specificity. J Neuropsychiatry Clin Neurosci 2007, 19:283–292.

    PubMed  Google Scholar 

  9. Ragin AB, Wu Y, Storey P, et al.: Diffusion tensor imaging of subcortical brain injury in patients infected with human immunodeficiency virus. J Neurovirol 2005, 11:292–298.

    Article  PubMed  Google Scholar 

  10. Wu Y, Storey P, Cohen BA, et al.: Diffusion alterations in corpus callosum of patients with HIV. Am J Neuroradiol 2006, 27:656–600.

    PubMed  CAS  Google Scholar 

  11. Hinkin CH, van Gorp WG, Mandelkern MA, et al.: Cerebral metabolic change in patients with AIDS: report of a six-month follow-up using positron-emission tomography. J Neuropsychiatry Clin Neurosci 1995, 7:180–187.

    PubMed  CAS  Google Scholar 

  12. Marcotte TD, Deutsch R, McCutchan JA, et al.: Prediction of incident neurocognitive impairment by plasma RNA and CD4 levels early after HIV seroconversion. Arch Neurol 2003, 60:1406–1412.

    Article  PubMed  Google Scholar 

  13. Hardy DJ, Hinkin CH, Levine AJ, et al.: Risky decision making assessed with the gambling task in adults with HIV. Neuropsychology 2006, 20:355–360.

    Article  PubMed  Google Scholar 

  14. American Academy of Neurology: Clinical confirmation of the American Academy of Neurology algorithm for HIV-1-associated cognitive/motor disorder. Neurology 1996, 47:1247–1253.

    Google Scholar 

  15. Antinori A, Arendt G, Becker JT, et al.: Updated research nosology for HIV-associated neurocognitive disorders. Neurology 2007, 69:1789–1799.

    Article  PubMed  CAS  Google Scholar 

  16. Robertson KR, Nakasujja N, Wong M, et al.: Pattern of neuropsychological performance among HIV positive patients in Uganda. BMC Neurology 2007, 7:8–15.

    Article  PubMed  Google Scholar 

  17. Vasan A, Renjifo B, Hertzmark E, et al.: Different rates of disease progression on HIV type 1 infection in Tanzania based on infecting subtype. Clin Infect Dis 2006, 42:843–852.

    Article  PubMed  Google Scholar 

  18. Wong M, Robertson K, Nakasujja N, et al.: Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa. Neurology 2007, 68:350–355.

    Article  PubMed  CAS  Google Scholar 

  19. Sacktor N: The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J Neurovirol 2002, 8(Suppl 2):115–121.

    Article  PubMed  CAS  Google Scholar 

  20. McArthur JC: HIV dementia. J Neuroimmunol 2004, 157:3–10.

    Article  PubMed  CAS  Google Scholar 

  21. Centers for Disease Control and Prevention: HIV/AIDS Surveillance Report, 2005. Atlanta: Department of Health and Human Services, Centers for Disease Control and Prevention; 2007.

    Google Scholar 

  22. Philips BR, Mole LA, Backus LI, et al.: Caring for Veterans With HIV Disease. Washington DC: Department of Veterans Affairs; 2003.

    Google Scholar 

  23. Valcour V, Shikuma C, Shiramizu B, et al.: Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort. Neurology 2004, 63:822–827.

    PubMed  CAS  Google Scholar 

  24. Sulkowski MS, Thomas DL: Hepatitis C in the HIV-infected person. Ann Intern Med 2003, 138:197–207.

    PubMed  Google Scholar 

  25. Greub G, Ledergerber B, Battegay M, et al.: Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet 2000, 356:1800–1805.

    Article  PubMed  CAS  Google Scholar 

  26. Hinkin CH, Castellon SA, Levine AJ, et al.: Neurocognition in individuals co-infected with HIV and hepatitis C. J Addict Dis 2008, 27:11–17.

    Article  PubMed  Google Scholar 

  27. Forton DM, Karayiannis P, Mahmud N, et al.: Identification of unique hepatitis C virus quasispecies in the central nervous system and comparative analysis of internal translational efficiency of brain, liver, and serum variants. J Virol 2004, 78:5170–5183.

    Article  PubMed  CAS  Google Scholar 

  28. Forton DM, Thomas HC, Murphy CA, et al.: Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology 2002, 35:433–439.

    Article  PubMed  Google Scholar 

  29. El-Serag HB, Hampel H, Yeh C, et al.: Extrahepatic manifestations of hepatitis C among United States male veterans. Hepatology 2002, 36:1439–1445.

    PubMed  Google Scholar 

  30. Taylor MJ, Alhassoon OM, Schweinsburg BC, et al.: MR spectroscopy in HIV and stimulant dependence. J Int Neuropsychol Soc 2000, 6:83–85.

    Article  PubMed  CAS  Google Scholar 

  31. Durvasula RS, Myers HF, Satz P, et al.: HIV-1, cocaine, and neuropsychological performance in African American men. J Int Neuropsychol Soc 2000, 6:322–335.

    Article  PubMed  CAS  Google Scholar 

  32. Levine AJ, Hardy DJ, Miller E, et al.: The effect of recent stimulant use on sustained attention in HIV-infected adults. J Clin Exp Neuropsychol 2004, 28:29–42.

    Article  Google Scholar 

  33. Martin EM, Pitrak DL, Weddington W, et al.: Cognitive impulsivity and HIV serostatus in substance dependent males. J Int Neuropsychol Soc 2004, 10:931–938.

    PubMed  Google Scholar 

  34. Levine AJ, Singer EJ, Shapshak P: The role of host genetic factors in the susceptibility for HIV-associated neurocognitive disorders. AIDS Behav 2008 Feb 9 [Epub ahead of print].

  35. van Rij RP, Portegies P, Hallaby R, et al.: Reduced prevalence of the CCR5 delta32 heterozygous genotype in human immunodeficiency virus-infected individuals with AIDS dementia complex. J Infect Dis 1999, 180:854–857.

    Article  PubMed  Google Scholar 

  36. Singh KK, Ellis RJ, Marquie-Beck J, et al.: sCCR5 polymorphisms affect neuropsychological impairment in HIV-1-infected individuals. J Neuroimmunol 2004, 157:185–192.

    Article  PubMed  CAS  Google Scholar 

  37. Kaul M, Lipton SA: Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc Natl Acad Sci U S A 1999, 96:8212–8216.

    Article  PubMed  CAS  Google Scholar 

  38. Valcour V, Shikuma C, Shiramizu B, et al.: Age, apolipoprotein E4, and the risk of HIV dementia: the Hawaii Aging With HIV cohort. J Neuroimmunol 2004, 157:197–202.

    Article  PubMed  CAS  Google Scholar 

  39. Suarez S, Baril L, Stankoff B, et al.: Outcome of patients with HIV-1-related cognitive impairment on highly active antiretroviral therapy. AIDS 2001, 15:195–200.

    Article  PubMed  CAS  Google Scholar 

  40. Hinkin CH, Hardy DJ, Mason KI, et al.: Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS 2004, 18(Suppl 1):S19–S25.

    PubMed  Google Scholar 

  41. Hinkin CH, Barclay TR, Castellon SA, et al.: Drug use and medication adherence among HIV-1 infected individuals. AIDS Behav 2007, 11:185–194.

    Article  PubMed  Google Scholar 

  42. Marcotte TD, Wolfson T, Rosenthal TJ, et al.: A multimodal assessment of driving performance in HIV infection. Neurology 2004, 63:1417–1422.

    PubMed  CAS  Google Scholar 

  43. Marcotte TD, Lazzaretto D, Scott JC, et al.: Visual attention deficits are associated with driving accidents in cognitively-impaired HIV-infected individuals. J Clin Exp Neuropsychol 2006, 28:13–28.

    Article  PubMed  Google Scholar 

  44. Heaton RK, Velin RA, McCutchan JA, et al.: Neuropsychological impairment in human immunodeficiency virus-infection: implications for employment. Psychosom Med 1994, 56:8–17.

    PubMed  CAS  Google Scholar 

  45. van Gorp WG, Rabkin JG, Ferrando SJ, et al.: Neuropsychiatric predictors of return to work in HIV/AIDS. J Int Neuropsychol Soc 2007, 13:80–89.

    PubMed  Google Scholar 

  46. Filippi CG, Ulu AM, Ryan E, et al.: Diffusion tensor imaging of patients with HIV and normal-appearing white matter on MR images of the brain. Am J Neuroradiol 2001, 22:277–283.

    PubMed  CAS  Google Scholar 

  47. Kieburtz K, Ketonen L, Cox C, et al.: Cognitive performance and regional brain volume in human immunodeficiency virus type 1 infection. Arch Neurol 1996, 53:155–158.

    PubMed  CAS  Google Scholar 

  48. Chang L, Ernst T, Leonido-Yee M, et al.: Cerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex. Neurology 1999, 52:100–108.

    PubMed  CAS  Google Scholar 

  49. Paul R, Cohen R, Navia B, et al.: Relationships between cognition and structural neuroimaging findings in adults with human immunodeficiency virus type-1. Neurosci Biobehav Rev 2002, 26:353–359.

    Article  PubMed  Google Scholar 

  50. Thompson PM, Dutton RA, Hayashi KM, et al.: Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD4+ lymphocyte decline. Proc Natl Acad Sci U S A 2005, 102:15647–15652.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Charles H. Hinkin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Foley, J., Ettenhofer, M., Wright, M. et al. Emerging issues in the neuropsychology of HIV infection. Curr HIV/AIDS Rep 5, 204–211 (2008). https://doi.org/10.1007/s11904-008-0029-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11904-008-0029-x

Keywords

Navigation